This inventor holds 1 USPTO granted patent. Top assignee: Inion Ltd.. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: **The Innovations of Tuomo Nieminen in Medical Implants**
Introduction
Tuomo Nieminen, an inventive mind based in Tampere, Finland, has made significant contributions to the field of medical technology. With one notable patent to his name, Nieminen focuses on developing innovative solutions that enhance medical implants, benefiting patients and healthcare providers alike.
Latest Patents
Nieminen's key patent, titled "Resorbable polymer composition, implant and method of making implant," presents novel polymer compositions that are particularly useful in producing medical implants. This invention is characterized by a polymer matrix composed of resorbable polymers or copolymers, combined with N-methyl-2-pyrrolidone (NMP), which imparts osteogenic properties to the composition. This advancement holds great promise for improving the functionality and biocompatibility of medical implants.
Career Highlights
At Inion Ltd., Nieminen works alongside a talented team that focuses on developing cutting-edge medical devices. His contributions have been vital in pushing the boundaries of what is possible in medical technology, especially in the realm of resorbable materials that aid the healing process in patients.
Collaborations
Throughout his career, Nieminen has collaborated with colleagues such as Eija Pirhonen and Jan Nieuwenhuis. Together, they share knowledge and expertise, facilitating the development of innovative solutions that address complex challenges in the medical field.
Conclusion
Tuomo Nieminen's work exemplifies the spirit of innovation in medical technology. His patented polymer compositions are expected to pave the way for enhanced medical implants, improving patient outcomes and revolutionizing treatment options in the field. As further developments emerge, Nieminen's contributions will undoubtedly continue to influence advancements in healthcare and medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
